NCT04312633View on ClinicalTrials.gov

Clinical Utility of WATS3D: A 5-Year Prospective Study

RecruitingOBSERVATIONAL

Enrollment

90,000

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

November 1, 2027

Study Completion Date

November 1, 2027

Conditions

Barrett EsophagusGastro Esophageal RefluxEsophageal DysplasiaEsophageal Diseases

Trial Locations (1)

11714

RECRUITING

NYU Langone Ambulatory Care, Bethpage

Sponsors

Lead Sponsor

CDx Diagnostics

All Listed Sponsors

lead

CDx Diagnostics

INDUSTRY

NCT04312633 - Clinical Utility of WATS3D: A 5-Year Prospective Study | Biotech Hunter | Biotech Hunter